Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
GeoVax Labs, Inc. (GOVX)
Standardized SEC financial data for GeoVax Labs, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000832489 · NASDAQ · Pharmaceutical Preparations.
Operating margin
-869.3%
Net margin
-862.3%
Revenue growth (YoY)
-37.1%
Return on equity
-561.1%
Free cash flow
-$21.5M
Current ratio
2.74×
EPS (diluted)
$-22.40
Ratios for fiscal year 2025, standardized from SEC filings.